Sales & Marketing News | pharmaphorum

News

Soriot with Prince (now King) Charles at the opening of the DISC facility in 2021

AZ shareholders back CEO Soriot’s pay package, amid dissent

Shareholders in AstraZeneca have voted to approve an 11% increase in the salary and bonus package for chief executive Pascal Soriot, although a sizeable minority did not a

News

US accuses Regeneron of fraud in Eylea price reporting

The US government has filed a lawsuit against Regeneron, claiming that the company falsely inflated the average sales price for ophthalmology blockbuster Eylea to manipula

News

Roche gets EU okay for first HER2-low test kit

Roche has obtained a CE Mark in the EU for a companion diagnostic that can be used to identify patients with HER2-low metastatic breast cancer who may be eligible for trea

News

UK calls time-out on post-Brexit rules opposed by industry

It has been more than four years since the UK left the EU, but the government is still being forced to delay the introduction of border control rules that could have conse

News

Enhertu gets FDA nod for tumour-agnostic HER2 cancers

The FDA has approved the use of AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Enhertu for all HER2-positive solid tumours, in a first for both HER2 inhibitors a

News

Carvykti, Abecma move earlier in multiple myeloma treatment

Johnson & Johnson and Legend Biotech’s BCMA-targeted CAR-T therapy Carvykti has been approved by the FDA to treat patients with multiple myeloma after at least one pri

AZ shareholders back CEO Soriot’s pay package, amid dissent

US accuses Regeneron of fraud in Eylea price reporting

Roche gets EU okay for first HER2-low test kit

UK calls time-out on post-Brexit rules opposed by industry

Enhertu gets FDA nod for tumour-agnostic HER2 cancers

Carvykti, Abecma move earlier in multiple myeloma treatment

Astellas pays $285m for Audax cancer drug, and other deals

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks